Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | EPZM | Common Stock, par value $0.0001 | Award | $0 | +16.7K | $0.00 | 16.7K | Nov 16, 2021 | Direct | F1, F2 |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | EPZM | Stock Option (Right to Buy) | Award | $0 | +83.3K | $0.00 | 83.3K | Nov 16, 2021 | Common Stock | 83.3K | $4.27 | Direct | F2, F3 |
Id | Content |
---|---|
F1 | Consists of shares of Common Stock issuable under 16,702 restricted stock units ("RSUs") granted pursuant to the Issuer's 2013 Stock Incentive Plan. Each RSU represents the right to receive one share of Common Stock upon vesting. These RSUs are scheduled to vest in three equal annual installments over three years from the grant date, with the first installment vesting on November 16, 2022, subject to continued service as a director. In the event of a change in control of the Issuer, the RSUs will vest in full. |
F2 | The number of shares of the Common Stock issuable upon exercise of the Option (as defined below) and underlying the RSUs granted to Dr. Beveridge accounts for adjustment based on the terms of the Issuer's non-employee director compensation program, which provides that the aggregate number of shares of Common Stock issuable upon exercise of the initial option grant and underlying the initial RSU grant to each new director shall in no event exceed a total of 100,000 shares. |
F3 | This option (the "Option") was granted on November 16, 2021 pursuant to the Issuer's 2013 Stock Incentive Plan with respect to 83,298 shares of Common Stock, with 33% vesting on November 16, 2022 and the remaining shares underlying the Option vesting in 24 substantially equal monthly installments thereafter, subject to continued service as a director. In the event of a change in control of the Issuer, the Option will vest in full. |